Sanofi Adr (SNY)

Feb 06, 2025

Respiratory Disease Vaccines Market Research Report 2025: Analysis and Forecast (2020-2030) Featuring GSK, Johnson & Johnson Services, Pfizer, Sanofi, Serum Institute of India, SINOVAC Biotech & More - GlobeNewswire Inc.

Feb 06, 2025

Feb 05, 2025

Sanofi ADR (SNY): A Technical Analysis - The News Heater

Feb 05, 2025

Feb 05, 2025

GNPX’s Market Whiplash: -38.94% YTD Decline, -42.28% Plunge in 30 Days - The InvestChronicle

Feb 05, 2025

Feb 05, 2025

Applied Materials Inc’s Banking’s 100-Day Moving Average at 182.60: Will the Stock Break Through? - The InvestChronicle

Feb 05, 2025

Feb 05, 2025

ESPR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 05, 2025

Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025

Jan 30, 2025

Sanofi Reports Strong Q4 Sales Growth, Plans €5 Billion Buyback in 2025 - GuruFocus.com

Jan 30, 2025

Jan 30, 2025

Sanofi ADR earnings beat by $0.53, revenue fell short of estimates - Investing.com South Africa

Jan 30, 2025

Jan 30, 2025

Sanofi ADR (SNY) Recovers 15.33% From Low: Are We There Yet? - Stocks Register

Jan 30, 2025

Jan 29, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Jan 29, 2025

Jan 27, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jan 27, 2025

Jan 25, 2025

AECOM (NYSE: ACM) Is A Blank Check For Growth - Stocks Register

Jan 25, 2025

Jan 25, 2025

Shares Of Pennymac Mortgage Investment Trust (NYSE: PMT): Are They Overvalued Compared To Others? - Stocks Register

Jan 25, 2025

Jan 17, 2025

7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - GlobeNewswire Inc.

Jan 17, 2025

Dec 23, 2024

Gsk Plc ADR (GSK-N) QuotePress Release - The Globe and Mail

Dec 23, 2024

Dec 23, 2024

3 Pharma Stocks To Buy As California Sounds The Alarm On Bird Flu Cases - Barchart

Dec 23, 2024

Dec 19, 2024

Communiqué de presse - GlobeNewswire Inc.

Dec 19, 2024

Dec 18, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Dec 18, 2024

Dec 18, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Dec 18, 2024

Dec 17, 2024

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily

Dec 17, 2024

Dec 17, 2024

What Did We Find About Insider Trading At Sanofi ADR (NASDAQ: SNY)? - Stocks Register

Dec 17, 2024

Dec 16, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 16, 2024

Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024

Dec 10, 2024

Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Dec 10, 2024